Document:

Exhibit 10.76

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED
OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED,
PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN THE
OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, SUCH QUALIFICATION AND REGISTRATION ARE NOT REQUIRED. ANY TRANSFER
OF THE SECURITIES REPRESENTED BY THIS NOTE IS FURTHER SUBJECT TO OTHER RESTRICTIONS, TERMS AND CONDITIONS WHICH ARE SET FORTH
HEREIN.

 

	Principal
    Amount: $20,000.00	Issue
    Date: January 11, 2021

 

NutraLife
Biosciences,
Inc.

 

10%
PROMISSORY NOTE

 

FOR
VALUE RECEIVED, pursuant to the terms and conditions of this 10% Promissory Note (this “Note”), NutraLife Biosciences,
Inc., a Florida corporation (the “Company”), hereby promises to pay to the
order of the holder as set forth on the signature page hereof, or registered assigns (the “Holder”), on
the one year anniversary of the Issue Date as set forth above (the “Maturity Date”) or earlier as required
pursuant to this Note, the principal amount as set forth above (the “Principal
Amount”), and to pay interest on the outstanding Principal Amount as set forth herein in each case to the extent that this
Note and the Principal Amount and any accrued interest hereunder (the “Indebtedness”) has not been repaid by the Company
as of such applicable date. Interest shall commence accruing on the date hereof (the “Issue Date”), computed on the
basis of a 365-day year and the actual number of days elapsed, and shall be payable as set forth herein.

 

This
Note is entered into pursuant to a Subscription Agreement by and between the Company and the Holder dated as of the Issue Date
(the “Agreement”) and is subject to the terms and conditions thereof.

 

This
Note is not a certificate of deposit or similar obligation of, and is not guaranteed or insured by, any depository institution,
the Federal Deposit Insurance Corporation, the Securities Holder Protection Corporation or any other governmental or private fund
or entity.

 

The
following terms shall apply to this Note:

 

Section 1. Definitions. Defined terms used herein without definition have the meanings given them in the Agreement. The Company and
the Holder may be referred to herein individually as a “Party” and collectively as the “Parties”.

 

Section 2. Interest; Late Fees; Prepayment.

 

(a)
Interest shall accrue on the Principal Amount
at the rate of ten percent (10%) per annum, simple interest, non-compounded basis (the “Interest”). To the extent
not earlier repaid as set forth herein, the Principal Amount and the accrued and unpaid Interest (collectively, the “Indebtedness”)
shall be due and payable in full on the Maturity Date or such earlier date as the Indebtedness may be due hereunder pursuant to
the terms herein. No payments of the Principal Amount or Interest herein shall be required prior to the Maturity Date.

 

    	1

     

    

 

(b)
The Company may prepay all or any portion of
the Principal Amount and any accrued and unpaid Interest at any time.

 

(c)
Whenever any payment or other obligation hereunder
shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

Section 3. Events of Default.

 

(a)
The Holder may elect to declare an “Event
of Default” if any of the following conditions or events shall occur and be continuing:

 

	 	(i)	the
    Company fails to pay the then-outstanding Indebtedness on any date any such amounts become due and payable, and any such failure
    is not cured within three Business Days of written notice thereof by Holder;
	 	 	 
	 	(ii)	any
    representation or warranty of the Company is materially false or untrue when given;
	 	 	 
	 	(iii)	the
    Company fails to comply in any material respect with any other covenant or agreement in this Note or in the Agreement and
    any such failure is not cured within three Business Days of written notice thereof by Holder;
	 	 	 
	 	(iv)	the
    Company shall (i) apply for or consent to the appointment of, or the taking of possession by, a receiver, custodian, trustee
    or liquidator; (ii) make a general assignment for the benefit of the Company’s creditors; or
	 	(iii)	commence
    a voluntary case under the U.S. Bankruptcy Code as now and hereafter in effect, or any successor statute; or
	 	 	 
	 	(v)	a
    proceeding or case shall be commenced, without the application or consent of the Company, in any court of competent jurisdiction,
    seeking (1) liquidation, reorganization or other relief with respect to it or its assets or the composition or readjustment
    of its debts, or (2) the appointment of a trustee, receiver, custodian, liquidator or the like of any substantial part of
    its assets, and, in each case, such proceedings or case shall continue undismissed, or an order, judgment or decree approving
    or ordering any of the foregoing shall be entered and continue unstayed and in effect, for a period of 60 days, if in the
    United States, or 90 days, if outside of the United States; or an order for relief against the Company shall be entered in
    an involuntary case under any bankruptcy, insolvency, composition, readjustment of debt, liquidation of assets or similar
    Law of any jurisdiction.
	 	 	 

(b)
Consequences of Events of Default. If
an Event of Default has occurred and is continuing (i) the Holder may, by notice to the Company, declare all or any portion of
the then- outstanding Indebtedness due and payable, and the Note and the then-outstanding Indebtedness shall thereupon become
immediately due and payable in cash and (ii) the Holder shall have the right to pursue any other remedies that the Holder may
have under applicable law.

 

    	2

     

    

 

Section 4. Miscellaneous.

 

(a)
Lost or Mutilated Note. If this Note shall
be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange and substitution for and upon cancellation
of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note, a new Note so mutilated, lost, stolen
or destroyed, but only upon receipt of evidence of such loss, theft or destruction of this Note, and of the ownership hereof reasonably
satisfactory to the Company.

 

(b)
Entire Agreement. This Note (including
any recitals hereto) and the Agreement set forth the entire understanding of the Parties with respect to the subject matter hereof,
and shall not be modified or affected by any offer, proposal, statement or representation, oral or written, made by or for any
Party in connection with the negotiation of the terms hereof, and may be modified only by instruments signed by the Company
and the Holder.

 

(c)
Notices. All notices under this Note shall
be in writing. Notices may be served by certified or registered mail, postage paid with return receipt requested; by private courier,
prepaid; by other reliable form of electronic communication; or personally. Mailed notices shall be deemed delivered five (5)
days after mailing, properly addressed. Couriered notices shall be deemed delivered on the date that the courier warrants that
delivery will occur. Electronic communication notices shall be deemed delivered when receipt is either confirmed by confirming
transmission equipment or acknowledged by the addressee or its office. Personal delivery
shall be effective when accomplished. Any Party may change its address by giving notice, in writing, stating its new address,
to the other Party. Subject to the forgoing, notices shall be sent as follows:

 

If
to the Company:

 

NutraLife
Biosciences, Inc.

Attn: Edgar Ward

6601
Lyons Road, Suite L-6

Coconut Creek, FL 33073

Email:
edgar@nutralifebiosciences.com

 

If
to Holder, to the address of Holder as set forth in the Agreement.

 

(d)
No Waiver. No waiver of any provision
of this Note shall be effective unless it is in writing and signed by the Party against whom it is asserted, and any such written
waiver shall only be applicable to the specific instance to which it relates and shall not be deemed to be a continuing or future
waiver.

 

(e)
Headings. The article and section headings
contained in this Note are inserted for convenience only and shall not affect in any way the meaning or interpretation of the
Note.

 

(f)
Governing Law. This Note, and any dispute
arising out of, relating to, or in connection with this Note, shall be governed by and construed in accordance with the laws of
the State of Florida, without giving effect to any choice or conflict of law provision or rule (whether of the State of Florida
or of any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Florida.

 

    	3

     

    

 

(g)
Enforcement of the Note; Jurisdiction; No
Jury Trial.

 

	 	(i)	Each
    of the Parties irrevocably agrees that any legal action or proceeding with respect to this Note and the rights and obligations
    arising under this Note, or for recognition and enforcement of any judgment or arbitral award or resolution in respect of
    this Note, shall be brought and determined exclusively in the courts of the State of Florida located in Broward County, Florida
    or in the event (but only in the event) that such courts do not have subject matter jurisdiction over such action or proceeding,
    in the United States District Court sitting in Broward County, Florida (the “Selected Courts”). Each of the Parties
    hereby irrevocably submits with regard to any such action or proceeding for itself and in respect of its property, generally
    and unconditionally, to the personal jurisdiction of the Selected Courts and agrees that it will not bring any action relating
    to this Note or any of the transactions contemplated by this Note in any court other than the Selected Courts. Each of the
    Parties hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in
    any action or proceeding with respect to this Note, (a) any claim that it is not personally subject to the jurisdiction of
    the Selected Courts for any reason other than the failure to serve in accordance with the provisions of this Note; (b) any
    claim that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced
    in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment,
    execution of judgment or otherwise); and (c) to the fullest extent permitted by law, any claim that (i) the suit, action or
    proceeding in such court is brought in an inconvenient forum; (ii) the venue of such suit, action or proceeding is improper;
    or (iii) this Note, or the subject matter of this Note, may not be enforced in or by the Selected Courts.
	 	 	 
	 	(ii)	EACH
    PARTY TO THIS AGREEMENT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT SUCH
    PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY SUIT, ACTION OR OTHER PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF,
    UNDER, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
	 	 	 
	 	(iii)	The
    Holder hereby expressly acknowledges that the agreements and restrictions contained herein are reasonable and necessary to
    protect the Company’s legitimate interests, that the Company would not have entered into this Note in the absence of
    such agreements and restrictions, and that any violation of such restrictions will result in irreparable harm to the Company.
    The Holder agrees that the Company shall be entitled to preliminary and permanent injunctive relief, without the necessity
    of proving actual damages, and specific performance of, as well as an equitable accounting of all earnings, profits and other
    benefits arising from any violation of, the agreements and restrictions contained herein, which rights shall be cumulative
    and in addition to any other rights or remedies to which the Company may be entitled. The Holder irrevocably and unconditionally
    (i) agrees that any legal proceeding arising out of this Note may be brought in the Selected Courts, (ii) consents to the
    non-exclusive jurisdiction of the Selected Courts in any such proceeding, and (iii) waives any objection to the laying of
    venue of any such proceeding in any Selected Court.

 

    	4

     

    

 

(h)
Attorneys’ Fees. If any Party hereto
is required to engage in litigation against any other Party, either as plaintiff or as defendant, in order to enforce or defend
any rights under this Note, and such litigation results in a final judgment in favor of such Party (“Prevailing Party”),
then the party or parties against whom said final judgment is obtained shall reimburse the Prevailing Party for all direct, indirect
or incidental expenses incurred, including, but not limited to, all attorneys’ fees, court costs and other expenses incurred
throughout all negotiations, trials or appeals undertaken in order to enforce the Prevailing Party’s rights hereunder.

 

(i)
Usury Savings Clause. Notwithstanding
any provision in this Note to the contrary, the total liability for payments of interest and payments in the nature of interest,
including, without limitation, all charges, fees, exactions, or other sums which may at any time be deemed to be interest, shall
not exceed the limit imposed by the usury laws of the jurisdiction governing this Note or any other applicable law. In the event
the total liability of payments of interest and payments in the nature of interest, including, without limitation, all charges,
fees, exactions or other sums which may at any time be deemed to be interest, shall, for any reason whatsoever, result in an effective
rate of interest, which for any month or other interest payment period exceeds the
limit imposed by the usury laws of the jurisdiction governing this Note, all sums in excess of those lawfully collectible as interest
for the period in question shall, without further agreement or notice by, between, or to any party hereto, be applied to the reduction
of the outstanding principal balance due hereunder immediately upon receipt of such sums by the Holder hereof, with the same force
and effect as though the Company had specifically designated such excess sums to be so applied to the reduction of the principal
balance then outstanding, and the Holder hereof had agreed to accept such sums as a penalty-free payment of principal; provided,
however, that the Holder may, at any time and from time to time, elect, by notice in writing to the Company, to waive, reduce,
or limit the collection of any sums in excess of those lawfully collectible as interest, rather than accept such sums as a prepayment
of the principal balance then outstanding. It is the intention of the Parties that the Company does not intend or expect to pay,
nor does the Holder intend or expect to charge or collect any interest under this Note greater than the highest non-usurious rate
of interest which may be charged under applicable law.

 

(j)
Parties in Interest. This Note shall be
binding upon and inure solely to the benefit of each Party, and nothing in this Note, express or implied, is intended to confer
upon any other person or entity any rights or remedies of any nature under or by reason of this Note.

 

(k)
Severability; Expenses; Further Assurances.
If any term, condition or other provision of this Note is determined by a court of competent jurisdiction to be invalid, illegal
or incapable of being enforced by any rule of law or public policy, all other terms, conditions and provisions of this Note shall
nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated by this
Note is not affected in any manner materially adverse to any Party. Upon such determination
that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good
faith to modify this Note so as to effect the original intent of the Parties as closely as possible in a mutually acceptable manner
in order that the transactions contemplated by this Note be consummated as originally contemplated to the fullest extent possible.
Except as otherwise specifically provided in this Note, each Party shall be responsible for the expenses it may incur in connection
with the negotiation, preparation, execution, delivery, performance and enforcement of this Note. The Parties shall from time
to time do and perform any additional acts and execute and deliver any additional documents and instruments that may be required
by Law or reasonably requested by any Party to establish, maintain or protect its rights and remedies under, or to effect the
intents and purposes of, this Note.

 

(l) Execution
in Counterparts, Electronic Transmission. This Note may be executed in any number of counterparts, each of which shall be
deemed an original. The signature of any Party which is transmitted by any reliable electronic means such as, but not limited
to, a photocopy, electronically scanned or facsimile machine, for purposes hereof, is to be considered as an original
signature, and the document transmitted is to be considered to have the same binding effect as an original signature or an
original document.

 

(m)
No Assignment. This Note may not be assigned
by either Party without the prior written consent of the other Party in its sole discretion.

 

(n)
Currency. All dollar amounts are in U.S.
dollars.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	5

     

    

 

IN
WITNESS WHEREOF, the undersigned has executed this Note as of the Issue Date.

 

	 	NutraLife
    Biosciences, Inc.
	 	 	 
	 	By:	/s/
    Edgar Ward
	 	Name: 	Edgar
    Ward
	 	Title:	Chief
    Executive Officer

 

Agreed
and accepted:

 

	Holder
    name: Gregory Ross	 
	 	 	 
	By:	/s/
    Gregory Ross	 
	Name: 	Gregory
    Ross	 

 

    	6Exhibit 10.77

 

NutraLife
Biosciences, Inc.

 

 

Subscription
Agreement

 

 

The
undersigned “Subscriber”, on the terms and conditions herein set forth, hereby irrevocable submits this subscription
agreement (the “Subscription Agreement”) to NutraLife Biosciences, Inc., a Florida corporation (the “Company”),
in connection with a private offering by the Company (the “Offering”) to raise a maximum of $200,000 through the sale
to Subscriber as an “accredited investor” (as defined below) of a Promissory Note of the Company (a “Note”)
and a Warrant of the Company (the “Warrant”) to acquire certain shares of common stock, par value $0.0001 per share,
of the Company (the “Common Stock”).

 

The
Company is offering up to $200,000 of aggregate principal amount of Notes and warrants to acquire up to 8,000,000 shares of Common
Stock.

 

For
each one dollar of aggregate principal amount of a Note that Subscriber subscribes for, the Subscriber shall be issued a warrant
to acquire forty shares of Common Stock, at a price of $0.08 per share, subject to customary adjustments as set forth in the Warrant.

 

By
way of example, and not limitation, in the event that Subscriber subscribed for a Note in the principal amount of $50,000, Subscriber
will be issued a Warrant to acquire 2,000,000 shares of Common Stock.

 

The
minimum subscription amount is a Note in the aggregate principal amount of $25,000, provided that the Company may accept subscriptions
in lesser amounts in its sole discretion.

 

The
principal amount of Note subscribed for and the Warrant to be issued is set forth below.

 

****

 

    	Page 1

    	 	 	 

    

 

Subscription:

 

The
undersigned Subscriber, intending to be legally bound, hereby subscribes for:

 

	 	(i)	a
    Note in the principal amount of $20,000.00 (the “Subscription Amount”); and
	 	 	 
	 	(ii)	A
    Warrant to acquire 800,000 shares of Common Stock.

 

The
Note is attached to this Subscription Agreement as Exhibit A and the Warrant is attached to this Subscription Agreement as Exhibit
B. The Note and the Warrant may be referred to herein collectively as the “Securities”.

 

The
undersigned acknowledges that the Company is offering the Securities to those who are “accredited investors” as defined
herein pursuant to of Rule 506(b) of Regulation D promulgated by the Securities Exchange Commission under the Securities Act of
1933, as amended (the “Securities Act”).

 

The
undersigned agrees to execute this Subscription Agreement and if by mail, send to the Company. You as an individual or you on
behalf of the subscribing entity are being asked to complete this Subscription Agreement so that a determination can be made as
to whether or not you (it) are qualified to purchase the Securities under applicable federal and state securities laws. Your answers
to the questions contained herein must be true and correct in all respects, and a false representation by you may constitute a
violation of law for which a claim for damages may be made against you. Your answers will be kept strictly confidential; however,
by signing this Subscription Agreement, you will be authorizing the Company to present a completed copy of this Subscription Agreement
to such parties as they may deem appropriate in order to make certain that the offer and sale of the securities will not result
in a violation of the Securities Act or of the securities laws of any state.

 

All
questions must be answered. If the appropriate answer is “None” or “Not Applicable,” please state so.
Please print or type your answers to all questions and attach additional sheets if necessary to complete your answers to any item.
Please initial any corrections.

 

	1.	Subscription
    for the Purchase of Securities. The undersigned Subscriber hereby subscribes to purchase the Securities as set forth above.
    Subscriber agrees to forward payment in the amount of the Subscription Price to the Company via one of the following methods:
	 	 	 
	 	(a)	by
    wiring payment of the Subscription Amount in accordance with the information set forth below:

 

For
                                         financial institutions in the United States, give your bank this information:

 

	 	Send
    to:	BB&T
	 	 	450
    N. Pine Island Rd. Plantation, FL. 33324
	 	 	ABA#
    263191387

 

    	Page 2

    	 	 	 

    

 

	 	For
    credit to:	NutraLife
    Biosciences, Inc.
	 	 	Attn:
    Edgar Ward
	 	 	6601
    Lyons Road, Suite L-6
	 	 	Coconut
    Creek, FL 33073
	 	 	Account
    # 241628361

 

	 	For
    the benefit of:	NutraLife
    Biosciences, Inc.
	 	 	6601
    Lyons Rd. L-6
	 	 	Coconut
    Creek Fl. 33073
	 	 	United
    States
	 	 	561.212.3816
    edgar.ward@nutralifebiosciences.com

 

For
financial institutions outside the United States, please contact the Company.

 

OR

 

	 	(b)	by
    mailing a certified check in the amount of the Subscription Price, payable to “NutraLife Biosciences, Inc.”, to
    the Company as follows:

 

NutraLife Biosciences, Inc.

Attn: Edgar Ward

6601 Lyons Road, Suite L-6

Coconut Creek, FL 33073

 

Regardless of whether
paying by wire transfer or check, you must also deliver a fully completed and executed copy of this Subscription Agreement and
an executed copy of the signature page to the Note and an executed copy of the signature page to the Warrant to the Company
at:

 

NutraLife
Biosciences, Inc.

Attn:
Edgar Ward

6601
Lyons Road, Suite L-6

Coconut
Creek, FL 33073

 

Subscriber
recognizes and agrees that (i) this subscription is irrevocable and, if Subscriber is a natural person, shall survive Subscriber’s
death, disability or other incapacity, and (ii) the Company has complete discretion to accept or to reject this Subscription Agreement
in its entirety and shall have no liability for any rejection of this Subscription Agreement. This Subscription Agreement shall
be deemed to be accepted by the Company only when it is executed by the Company.

 

    	Page 3

    	 	 	 

    

 

	2.	Effect
    of Acceptance. Subscriber hereby acknowledges and agrees that on the Company’s acceptance of this Subscription Agreement,
    it shall become a binding and fully enforceable agreement between the Company and the Subscriber. As a result, upon acceptance
    by the Company of this Subscription Agreement, Subscriber will become the record and beneficial holder of the Securities and
    the Company will be entitled to receive the purchase price of the Securities as specified herein. By Subscriber’s execution
    of this Subscription Agreement, Subscriber agrees to the bound by the terms and conditions of the Note and the Warrant.
	 	 
	3.	Representation
    as to Investor Status. In order for the Company to sell the Securities (in conformance with state
    and federal securities laws), the following information must be obtained regarding Subscriber’s investor status. Please
    initial each item applicable to you as an investor in the Company.

 

	 	(a)	Accredited
    Investor. Rule 501(a) of Regulation D defines an “accredited investor” as any person who comes within any
    of the following categories, or whom the issuer reasonably believes comes within any of the following categories, at the time
    of the sale of the securities to that person:
	 	 	 	 
	 	 	(i)	
    _____ A natural person whose net worth, either individually or jointly with such person’s spouse, at the time of
    Subscriber’s purchase, exceeds $1,000,000.
	 	 	 	 
	 	 	(ii)	   GR     A natural person who had an individual
    income in excess of $200,000, or joint income with that person’s spouse in excess of $300,000, in each of the two most
    recent years and reasonably expects to reach the same income level in the current year.
	 	 	 	 
	 	 	(iii)	_____
    A bank as defined in Section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined
    in Section 3(a)(5)(A) of the Securities Act, whether acting in its individual or fiduciary capacity. 
	 	 	 	 
	 	 	(iv)	_____
    A broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended (the “Exchange
    Act”).
	 	 	 	 
	 	 	(v)	_____
    An insurance company as defined in section 2(13) of the Exchange Act.
	 	 	 	 
	 	 	(vi)	_____
    An investment company registered under the Investment Company Act of 1940 or a business development company as defined in
    Section 2(a)(48) of that Act.
	 	 	 	 
	 	 	(vii)	_____
    A Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the
    Small Business Investment Act of 1958.
	 	 	 	 
	 	 	(viii)	_____
    A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state, or
    its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000.
	 	 	 	 
	 	 	(ix)	_____
    An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision
    is made by a plan fiduciary, as defined in Section 3(21) of such act, which is either a bank, savings and loan association,
    insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000
    or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors.

 

    	Page 4

    	 	 	 

    

 

	 	 	(x)	_____
    A private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940.
	 	 	 	 
	 	 	(xi)	_____
    An organization described in Section 501(c)(3) of the Internal Revenue Code, or a corporation, business trust or partnership,
    not formed for the specific purpose of acquiring the Securities, with total assets in excess of $5,000,000.
	 	 	 	 
	 	 	(xii)	_____
    A director or executive officer of the Company.
	 	 	 	 
	 	 	(xiii)	_____
    A trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Securities, whose
    purchase is directed by a sophisticated person who has such knowledge and experience in financial and business matters that
    such person is capable of evaluating the merits and risks of investing in the Company.
	 	 	 	 
	 	 	(xiv)	_____
    An entity in which all of the equity owners qualify under any of the above subparagraphs.
	 	 	 	 
	 	 	________
    Subscriber does not qualify under any of the investor categories set forth in Section (3)(a)(i) through Section (3)(a)(iv).
	 	 	 	 
	 	 	The term “net worth” means the excess of
total assets over total liabilities (including personal and real property, but excluding the estimated fair market value of a
person’s primary home).
	 	 	 	 
	 	 	In determining individual “income,” Subscriber
should add to Subscriber’s individual taxable adjusted gross income (exclusive of any spousal income) any amounts attributable
to tax exempt income received, losses claimed as a limited partner in any limited partnership, deductions claimed for depletion,
contributions to an IRA or Keogh retirement plan, alimony payments, and any amount by which income from long-term capital gains
has been reduced in arriving at adjusted gross income.
	 	 	 	 
	 	(b)
    	Type
    of Subscriber. Indicate the form of entity of Subscriber:

 

	 	[X]	Individual	[  ]	Limited
    Partnership
	 	 	 	 	 
	 	[  ]	Corporation	[  ]	General
    Partnership
	 	 	 	 	 
	 	[  ]	Revocable
    Trust	[  ]	Other
    Type of Trust (indicate type): ___________
	 	 	 	 	 
	 	[  ]	Other
    (indicate form of organization): _________________________________________________
	 	 	 
	 	(i)	If
    Subscriber is not an individual, indicate the approximate date Subscriber entity was formed: ________________________.

 

    	Page 5

    	 	 	 

    

 

	 	(ii)	If
    Subscriber is not an individual, initial the line below which correctly describes the application of
    the following statement to Subscriber’s situation: Subscriber (x) was not organized or reorganized for the specific
    purpose of acquiring the Securities and (y) has made investments prior to the date hereof, and each beneficial owner thereof
    has and will share in the investment in proportion to his or her ownership interest in Subscriber.

 

________               True

 

________              
False

 

	 	If
    the “False” box is checked, each person participating in the entity will be required to fill out a Subscription
    Agreement.

 

	4.	Additional
    Representations and Warranties of Subscriber. Subscriber hereby represents and warrants to the Company as follows:
	 	 
	 	(a)	Subscriber
    has been furnished all documents related to the Company and its operations as requested by Subscriber, and Subscriber has
    carefully read such documents. Subscriber has been furnished with all documents and materials relating to the business, finances
    and operations of the Company and information that Subscriber requested and deemed material to making an informed investment
    decision regarding its purchase of the Securities. Subscriber has been afforded the opportunity to review such documents and
    materials and the information contained therein. Subscriber has been afforded the opportunity to ask questions of the Company
    and its management. Subscriber understands that such discussions, as well as any written information provided by the Company,
    were intended to describe the aspects of the Company’s business and prospects which the Company believes to be material,
    but were not necessarily a thorough or exhaustive description, and except as expressly set forth in this Subscription Agreement,
    the Company makes no representation or warranty with respect to the completeness of such information and makes no representation
    or warranty of any kind with respect to any information provided by any entity other than the Company. Some of such information
    may include projections as to the future performance of the Company, which projections may not be realized, may be based on
    assumptions which may not be correct and may be subject to numerous factors beyond the Company’s control. Additionally,
    Subscriber understands and represents that Subscriber is purchasing the Securities notwithstanding the fact that the Company
    may disclose in the future certain material information that the Subscriber has not received, including the financial results
    of the Company for their current fiscal quarters. Neither such inquiries nor any other due diligence investigations conducted
    by such Subscriber shall modify, amend or affect such Subscriber’s right to rely on the Company’s representations
    and warranties, if any, contained in this Subscription Agreement. Subscriber has sought such accounting, legal and tax advice
    as it has considered necessary to make an informed investment decision with respect to its investment in the Securities. Subscriber
    has full power and authority to make the representations referred to herein, to purchase the Securities and to execute and
    deliver this Subscription Agreement.

 

    	Page 6

    	 	 	 

    

 

	 	(b)	Subscriber
    has read and understood, and is familiar with, this Subscription Agreement, the Securities and the business and financial
    affairs of the Company.
	 	 	 
	 	(c)	Subscriber, either personally, or together with Subscriber’s advisors (other than any securities broker/dealers who may receive
compensation from the sale of any of the Securities), has such knowledge and experience in financial and business matters as to be capable
of evaluating the merits and risks of an investment in the Securities, is able to bear the risks of an investment in the Securities and
understands the risks of, and other considerations relating to, a purchase of a Unit. The Subscriber and its advisors have had a reasonable
opportunity to ask questions of and receive answers from the Company con-cerning the Securities. Subscriber’s financial condition
is such that Subscriber is able to bear the risk of holding the Securities that Subscriber may acquire pursuant to this Subscription Agreement,
for an indefinite period of time, and the risk of loss of Subscriber’s entire investment in the Company.
	 	 	 
	 	(d)	Subscriber
    has investigated the acquisition of the Securities to the extent Subscriber deemed necessary or desirable and the Company
    has provided Subscriber with any reasonable assistance Subscriber has requested in connection therewith.
	 	 	 
	 	(e)	The
    Securities are being acquired for Subscriber’s own account for investment, with no intention by Subscriber to distribute
    or sell any portion thereof within the meaning of the Securities Act, and will not be transferred by Subscriber in violation
    of the Securities Act or the then applicable rules or regulations thereunder. No one other than Subscriber has any interest
    in or any right to acquire the Securities. Subscriber understands and acknowledges that the Company will have no obligation
    to recognize the ownership, beneficial or otherwise, of the Securities by anyone but Subscriber.
	 	 	 
	 	(f)	No
    representations or warranties have been made to Subscriber by the Company, or any representative of the Company, or any securities
    broker/dealer, other than as set forth in this Subscription Agreement.
	 	 	 
	 	(g)	Subscriber
    is aware that Subscriber’s rights to transfer the Securities is restricted by the Securities Act and applicable state
    securities laws, and Subscriber will not offer for sale, sell or otherwise transfer the Securities without registration under
    the Securities Act and qualification under the securities laws of all applicable states, unless such sale would be exempt
    therefrom.
	 	 	 
	 	(h)	Subscriber
    understands and agrees that the Securities have not been registered under the Securities Act or any state securities act in
    reliance on exemptions therefrom and that the Company has no obligation to register any of the Securities.
	 	 	 
	 	(i)	The
    Subscriber has had an opportunity to ask questions of, and receive answers from, representatives of the Company concerning
    the terms and conditions of this investment and all such questions have been answered to the full satisfaction of the undersigned.
    Subscriber understands that no person other than the Company has been authorized to make any representation and if made, such
    representation may not be relied on unless it is made in writing and signed by the Company. The Company has not, however,
    rendered any investment advice to the undersigned with respect to the suitability.

 

    	Page 7

    	 	 	 

    

 

	 	(j)	Subscriber
    understands that the certificates or other instruments representing the Securities shall bear a restrictive legend in substantially
    the following form (and a stop transfer order may be placed against transfer of such certificates):
	 	 	 	 
	 	 	THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS, AND
NO INTEREST MAY BE SOLD, DISTRIBUTED, ASSIGNED, OFFERED, PLEDGED OR OTHERWISE TRANSFERRED UNLESS (A) THERE IS AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS COVERING ANY SUCH TRANSACTION INVOLVING SAID SECURITIES, (B) THIS
CORPORATION RECEIVES AN OPINION OF LEGAL COUNSEL FOR THE HOLDER OF THESE SECURITIES SATISFACTORY TO THIS CORPORATION STATING THAT
SUCH TRANSACTION IS EXEMPT FROM REGISTRATION, OR (C) THIS CORPORATION OTHERWISE SATISFIES ITSELF THAT SUCH TRANSACTION IS EXEMPT
FROM REGISTRATION.
	 	 	               	 
	 	(k)	Subscriber
    also acknowledges and agrees to the following:

 

	 	 	(i)	an
    investment in the Securities is highly speculative and involves a high degree of risk of loss of the entire investment in
    the Company; and
	 	 	 	 
	 	 	(ii)	there
    is no assurance that a public market for the will be available and that, as a result, Subscriber may not be able to liquidate
    Subscriber’s investment in the Securities should a need arise to do so.

 

	 	(l)	Subscriber
    is not dependent for liquidity on any of the amounts Subscriber is investing in the Securities.
	 	 	 	 
	 	(m)	Subscriber’s
    address set forth below is his or her or its correct residence or business address.
	 	 	 	 
	 	(n)	Subscriber
    has full power and authority to make the representations referred to herein, to purchase the Securities and to execute and
    deliver this Subscription Agreement.
	 	 	 
	 	(o)	Subscriber
    understands that the foregoing representations and warranties are to be relied upon by the Company as a basis for the exemptions
    from registration and qualification of the sale of the Securities under the federal and state securities laws and for other
    purposes.

 

    	Page 8

    	 	 	 

    

 

	5.	Representations
    and Warranties Regarding Patriot Act; Anti-Money Laundering; OFAC. The Subscriber should check the Office of Foreign Assets
    Control (“OFAC”) website at http://www.treas.gov/ofac before making the following representations. Subscriber
    hereby represents and warrants to the Company as follows:
	 	 	 
	 	(a)	The
    Subscriber represents that (i) no part of the funds used by the Subscriber to acquire the Securities or to satisfy his/her
    capital commitment obligations with respect thereto has been, or shall be, directly or indirectly derived from, or related
    to, any activity that may contravene United States federal or state or non-United States laws or regulations, including anti-money
    laundering laws and regulations, and (ii) no capital commitment, contribution or payment to the Company by the Subscriber
    and no distribution to the Subscriber shall cause the Company to be in violation of any applicable anti-money laundering laws
    or regulations including, without limitation, Title III of the Uniting and Strengthening America by Providing Appropriate
    Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001 and the United States Department of the Treasury
    Office of Foreign Assets Control regulations. The Subscriber acknowledges and agrees that, notwithstanding anything to the
    contrary contained in any other agreement, to the extent required by any anti-money laundering law or regulation, the Company
    may prohibit capital contributions, restrict distributions or take any other reasonably necessary or advisable action with
    respect to the Securities, and the Subscriber shall have no claim, and shall not pursue any claim, against the Company or
    any other person in connection therewith. U.S. federal regulations and executive orders administered by OFAC prohibit, among
    other things, the engagement in transactions with, and the provision of services to, certain foreign countries, territories,
    entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found on the OFAC
    website at http://www.treas.gov/ofac. In addition, the programs administered by OFAC (the “OFAC Programs”) prohibit
    dealing with individuals1 or entities in certain countries regardless of whether such individuals
    or entities appear on the OFAC lists.
	 	 	 
	 	(b)	To the best of the Subscriber’s knowledge, none of: (1) the Subscriber; (2) any person controlling or controlled by the Subscriber;
(3) if the Subscriber is a privately-held entity, any person having a beneficial interest in the Subscriber; or (4) any person for whom
the Subscriber is acting as agent or nominee in connection with this investment is a country, territory, individual or entity named on
an OFAC list, or a person or entity prohibited under the OFAC Programs. Please be advised that the Company may not accept any amounts
from a prospective investor if such prospective investor cannot make the representation set forth in this paragraph. The Subscriber agrees
to promptly notify the Company should the Subscriber become aware of any change in the information set forth in these representations.
The Subscriber understands and acknowledges that, by law, the Company may be obligated to “freeze the account” of the Subscriber,
either by prohibiting additional subscriptions from the Subscriber, declining any redemption requests and/or segregating the assets in
the account in compliance with governmental regulations, and any broker may also be required to report such action and to disclose the
Subscriber’s identity to OFAC. The Subscriber further acknowledges that the Company may, by written notice to the Subscriber, suspend
the redemption rights, if any, of the Subscriber if the Company reasonably deems it necessary to do so to comply with anti-money laundering
regulations applicable to the Company or any Broker or any of the Company’s other service providers. These individuals include specially
designated nationals, specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs.

 

 

 

	1	These
    individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject to
    OFAC sanctions and embargo programs.

 

    	Page 9

    	 	 	 

    

 

	 	(c)	To the best of the Subscriber’s knowledge, none of: (1) the Subscriber; (2) any person controlling or controlled by the
    Subscriber; (3) if the Subscriber is a privately-held entity, any person having a beneficial interest in the Subscriber; or
    (4) any person for whom the Subscriber is acting as agent or nominee in connection with this investment is a senior foreign
    political figure2, or any immediate family3 member or close associate4 of a senior foreign
    political figure, as such terms are defined in the footnotes below.
	 	 	 
	 	(d)	If
    the Subscriber is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Subscriber receives
    deposits from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Subscriber
    represents and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address,
    in a country in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating
    records related to its banking activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed
    the Foreign Bank to conduct banking activities; and (4) the Foreign Bank does not provide banking services to any other Foreign
    Bank that does not have a physical presence in any country and that is not a regulated affiliate.
	 	 	 
	 	(e)	The Subscriber acknowledges that, to the extent applicable, the Company will seek to comply with the Foreign Account Tax Compliance Act
provisions of the U.S. Internal Revenue Code and any rules, regulations, forms, instructions or other guidance issued in connection therewith
(the “FATCA Provisions”). In furtherance of these efforts, the Subscriber agrees to promptly deliver any additional documentation
or information, and updates thereto as applicable, which the Company may request in order to comply with the FATCA Provisions. The Subscriber
acknowledges and agrees that, notwithstanding anything to the contrary contained in any side letter or any other agreement, the failure
to promptly comply with such requests, or to provide such additional information, may result in the withholding of amounts with respect
to, or other limitations on, distributions made to the Subscriber and such other reasonably necessary or advisable action by the Company
with respect to the Securities (including, without limitation, required withdrawal), and the Subscriber shall have no claim, and shall
not pursue any claim, against the Company or any other person in connection therewith

 

The
foregoing representations and warranties are true and accurate as of the date hereof and shall survive such date. If any of
the above representations and warranties shall cease to be true and accurate prior to the acceptance of this Subscription
Agreement, Subscriber shall give prompt notice of such fact to the Company by telegram, or facsimile or e-mail, specifying
which representations and warranties are not true and accurate and the reasons therefor.

 

 

 

	2	A
    “senior foreign political figure” is defined as a senior official in the executive, legislative, administrative,
    military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political
    party, or a senior executive of a foreign government-owned corporation. In addition, a “senior foreign political figure”
    includes any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political
    figure.
	 	 
	3	“Immediate
    family” of a senior foreign political figure typically includes the figure’s parents, siblings, spouse, children
    and in-laws.
	 	 
	4	A
    “close associate” of a senior foreign political figure is a person who is widely and publicly known to maintain
    an unusually close relationship with the senior foreign political figure, and includes a person who is in a position to conduct
    substantial domestic and international financial transactions on behalf of the senior foreign political figure.

 

    	Page 10

    	 	 	 

    

 

	6.	Indemnification.
    Subscriber acknowledges that Subscriber understands the meaning and legal consequences of the representations and warranties
    made by Subscriber herein, and that the Company is relying on such representations and warranties in making the determination
    to accept or reject this Subscription Agreement. Subscriber hereby agrees to indemnify and hold harmless the Company and each
    employee and agent thereof from and against any and all losses, damages or liabilities due to or arising out of a breach of
    any representation or warranty of Subscriber contained in this Subscription Agreement.
	 	 
	7.	Transferability.
    Subscriber agrees not to transfer or assign this Subscription Agreement, or any interest herein, and further agrees that
    the assignment and transferability of the Securities acquired pursuant hereto shall be made only in accordance with applicable
    federal and state securities laws.
	 	 
	8.	Termination
    of Agreement; Return of Funds. In the event that, for any reason, this Subscription Agreement is rejected in its entirety
    by the Company, this Subscription Agreement shall be null and void and of no further force and effect, and no party shall
    have any rights against any other party hereunder. In the event that the Company rejects this Subscription Agreement, the
    Company shall promptly return or cause to be returned to Subscriber any money tendered hereunder without interest or deduction.
	 	 
	9.	Notices.
    All notices or other communications given or made hereunder shall be in writing and shall be delivered or mailed by registered
    or certified mail, return receipt requested, postage prepaid, or delivered by, facsimile or e-mail to Subscriber at the address
    set forth below and to the Company at the address set forth above, or at such other place as the Company may designate by
    written notice to Subscriber.
	 	 
	10.	Amendments.
    Neither this Subscription Agreement nor any term hereof may be changed, waived, discharged or terminated except in a writing
    signed by Subscriber and the Company.
	 	 
	11.	Governing
    Law. This Subscription Agreement and all amendments hereto shall be governed by and construed in accordance with the laws
    of the State of Florida without application of the conflicts of laws provisions thereof.
	 	 
	12.	Headings.
    The headings in this Subscription Agreement are for convenience of reference, and shall not by themselves determine the
    meaning of this Subscription Agreement or of any part hereof.
	 	 
	13.	Counterparts.
    This Subscription Agreement may be executed in any number of counterparts with the same force and effect as if all parties
    had executed the same document. The execution and delivery of a facsimile or other electronic transmission of this Subscription
    Agreement shall constitute delivery of an executed original and shall be binding upon the person whose signature appears on
    the transmitted copy.
	 	 
	14.	Continuing
    Obligation of Subscriber to Confirm Investor Status. Upon the request of the Company and for as long
    as the Subscriber holds Securities or other securities in the Company, the Subscriber shall confirm Subscriber’s investor
    status as an “Accredited Investor,” as defined by the Securities and Exchange Commission at the time of such request.
    In connection therewith, the Company shall deliver to the Subscriber a questionnaire that elicits the necessary information
    to determine the Subscriber’s investor status. Upon receipt of the questionnaire, the Subscriber shall: (i) complete
    it, (ii) execute the signature page therein, and (iii) return it to the Company, or its designee, in accordance with the instructions
    therein, no later than ten (10) days after receipt of the questionnaire.

 

[Remainder
of page intentionally left blank. Signatures appear on following pages.]

 

    	Page 11

    	 	 	 

    

 

In
witness whereof, the parties hereto have executed this Subscription Agreement as of the dates set forth below.

 

Dated:
January 11, 2021.

 

	Signature:
    	/s/
    Gregory Ross	 
	 	 	 
	Name
    (Please Print): 	Gregory Ross	 
	 	 	 
	Residence
    Address: 	515 Windermere Lane	 
	 	Annoyo Grande, CA 93240	 
	 	 	 
	Phone
    Number: 	(_____)
    ______-__________________	 
	 	 	 
	Cellular
    Number:	(559) 805 - 4209	 
	 	 	 
	Social
    Security Number(s):	###-##-####	 
	 	 	 
	Email
    address:	drosscva@gmail.com	 

 

	 	ACCEPTANCE
	 	 
	 	NutraLife
    Biosciences, Inc.
	 	 	 
	Date:
    January 11, 2021.	 	 
	 	 	 
	 	By:	/s/
    Edgar Ward
	 	Name: 	Edgar
    Ward
	 	Title:	Chief
    Executive Officer

 

    	Page 12

    	 	 	 

    

 

Exhibit
A

Promissory
Note

 

(Attached)

 

    	 	 	 

    	 	 	 

    

 

Exhibit
B

Warrant

 

(Attached)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]